-- AlphaValue/Baader Europe on Monday upgraded Swiss pharmaceutical manufacturer Lonza Group (LONN.SW) to buy from add and raised its price target to 646 francs from 644 francs.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)